1. HAX1 Augments Cell Proliferation, Migration, Adhesion, and Invasion Induced by Urokinase-Type Plasminogen Activator Receptor. (17th January 2012) Authors: Mekkawy, Ahmed H.; Morris, David L.; Pourgholami, Mohammad H. Other Names: Singh K. K. Academic Editor. Journal: Journal of oncology Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Involvement of Urokinase‐Type Plasminogen Activator System in Cancer: An Overview. Issue 5 (18th February 2014) Authors: Mekkawy, Ahmed H.; Pourgholami, Mohammad H.; Morris, David L. Journal: Medicinal research reviews Issue: Volume 34:Issue 5(2014:Sep.) Page Start: 918 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MUC1 as a Potential Target in Anticancer Therapies. (February 2015) Authors: Pillai, Krishna; Pourgholami, Mohammad H.; Chua, Terence C.; Morris, David L. Journal: American journal of clinical oncology Issue: Volume 38:Number 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MUC1 as a Potential Target in Anticancer Therapies. (February 2015) Authors: Pillai, Krishna; Pourgholami, Mohammad H.; Chua, Terence C.; Morris, David L. Journal: American journal of clinical oncology Issue: Volume 38:Number 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MUC1 has Prognostic Significance in Malignant Peritoneal Mesothelioma. Issue 3 (July 2013) Authors: Pillai, Krishna; Pourgholami, Mohammad H.; Chua, Terence C.; Morris, David L. Journal: International journal of biological markers Issue: Volume 28:Issue 3(2013) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prognostic Significance of Ki67 Expression in Malignant Peritoneal Mesothelioma. (August 2015) Authors: Pillai, Krishna; Pourgholami, Mohammad H.; Chua, Terence C.; Morris, David L. Journal: American journal of clinical oncology Issue: Volume 38:Number 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic Significance of Ki67 Expression in Malignant Peritoneal Mesothelioma. (August 2015) Authors: Pillai, Krishna; Pourgholami, Mohammad H.; Chua, Terence C.; Morris, David L. Journal: American journal of clinical oncology Issue: Volume 38:Number 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The role of ERα36 in cell type-specific functions of estrogen and cancer development. (January 2021) Authors: Mahboobifard, Fatemeh; Dargahi, Leila; Jorjani, Masoumeh; Ramezani Tehrani, Fahimeh; Pourgholami, Mohammad H. Journal: Pharmacological research Issue: Volume 163(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application. (26th September 2011) Authors: Amini, Afshin; Masoumi Moghaddam, Samar; Morris, David L.; Pourgholami, Mohammad H. Other Names: Dudek Arkadiusz Academic Editor. Journal: Journal of oncology Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗